On Wednesday, November 14, Robert Perez, President and COO, will
present at 2:20 p.m. Greenwich Mean Time, at the Jefferies 2012 Global
Healthcare Conference being held at The Waldorf Hilton Hotel in
audio with slides webcast)
On Monday, November 19, Steven Gilman, EVP and Chief Scientific
Officer will host one-on-one meetings at the Mayflower Management
Access Day being held at Leerink Swann’s headquarters in Boston. Mr.
Gilman will be joined by Eileen C. McIntyre, Senior Director, Investor
Relations. These meetings will not be webcast.
On Thursday, November 29, Greg Stea, SVP Commercial Operations; and
Michael Tomsicek, SVP and Deputy CFO will host one-on-one meetings at
the 2012 RBC Capital Markets’ Healthcare Investor Day at the JW
Marriott, Denver, Cherry Creek. Mr. Stea and Mr. Tomsicek will be
joined by Eileen C. McIntyre, Senior Director, Investor Relations.
These meetings will not be webcast.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the research, development, and commercialization of pharmaceutical
products that address significant unmet medical needs in the acute care
environment. Cubist is headquartered in Lexington, Mass. Additional
information can be found at Cubist’s website.
INVESTORS: Cubist Pharmaceuticals, Inc. Eileen
C. McIntyre, 781-860-8533 Senior Director, Investor Relations firstname.lastname@example.org or MEDIA: Cubist
Pharmaceuticals, Inc. Julie DiCarlo, 781-860-8063 Senior
Director, Corporate Communications email@example.com